Livzon Pharmaceutical repurchases A shares, issued share capital unchanged

Livzon Pharmaceutical Group Inc. submitted its Next Day Disclosure Return on September 23, 2025, detailing share movements up to that date, with its H-share capital remaining constant at 299,807,117 ordinary H shares.

The report highlighted extensive repurchases of A shares, which totaled 604,293,313 as of September 23, 2025. On September 23, 2025, 131,000 A shares were repurchased at an aggregate price of 4,997,212 yuan, with prices ranging from 37.71 yuan to 38.79 yuan. These repurchased shares are pending cancellation.

The disclosure also listed numerous A-share repurchases between December 25, 2024, and September 23, 2025, with quantities ranging from 1,700 to 561,400 shares on individual dates, and prices varying between 34.00 yuan and 41.99 yuan. The shares totaling 131,000 as of the reporting date are yet to be cancelled.